CD4 and tuberculosis: During the study period, a total of 4,257 PLWH had CD4 < 200 cells/μL at some stage during ART (AHD among ART-experienced), of which 1,923 (45.2%) were men, 174 (4.2%) were on TB treatment and 2,868 (67.4%) were on TDF+FTC/3TC based regimen.